![Andrew Neil Charles Weir](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Neil Charles Weir
Vorstandsvorsitzender bei Sitryx Therapeutics Ltd.
Aktive Positionen von Andrew Neil Charles Weir
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sitryx Therapeutics Ltd.
![]() Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.04.2018 | - |
Vorstandsvorsitzender | 01.04.2018 | - |
Karriereverlauf von Andrew Neil Charles Weir
Statistik
International
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sitryx Therapeutics Ltd.
![]() Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |